Join us on our eighth webinar session for a lively discussion with our researcher Michael Felderhoff, from the Max-Planck-Institut für Kohlenforschung. We’ll talk about ball mills and how to use them to scale up mechanochemical transformations from milligrams to kilograms. Save the date: it will take place on Thursday, 28 May at 16:00 CEST.
Scaling up from milligrams to kilograms is no easy task, but our Swiss partner has what it takes: the Dyno®-Mill, a specific type of bead mill that complements the abilities and resources of the rest of the consortium.
The report highlights IMPACTIVE as a direct result of the success of the MechSustInd COST Action, which built an international network and advanced mechanochemistry as a whole.
Our partner DesSolutio bridges chemistry and engineering to help scale up mechanochemical processes within IMPACTIVE. Discover how in this blogpost.
We are thrilled to announce our seventh webinar session. Save the date: it will take place on Wednesday, 11 March at 17:00 CET and will feature a presentation by our researcher Juan Martín Pividori, from DesSolutio.
What actually happens inside a mechanochemical reaction? Our partner the BAM Institute analyses reactions as they occur to unravel how atoms and molecules behave.
We are thrilled to announce our sixth webinar session. Save the date: it will take place on 11 February at 16:00 CET, featuring a presentation by Vânia André, IMPACTIVE researcher from IST-ID.
Meet our partner Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento (IST-ID), who develops multicomponent systems to enhance the properties of our molecules. They also carry out the critical task of characterising the compounds that IMPACTIVE synthesises.
We’re turning three years old, and we’re celebrating by publishing our latest Annual Report, which summarises our developments over the past year.
Our researchers at Trinity College Dublin, in Ireland, master the spray drying technique. This team is exploring how to apply such method to achieve greener pharmaceuticals with a strong focus on industrial production.